[go: up one dir, main page]

RU99111071A - MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS - Google Patents

MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS

Info

Publication number
RU99111071A
RU99111071A RU99111071/13A RU99111071A RU99111071A RU 99111071 A RU99111071 A RU 99111071A RU 99111071/13 A RU99111071/13 A RU 99111071/13A RU 99111071 A RU99111071 A RU 99111071A RU 99111071 A RU99111071 A RU 99111071A
Authority
RU
Russia
Prior art keywords
hemopoethic
agonists
receptors
multifunctional chimeric
chimeric
Prior art date
Application number
RU99111071/13A
Other languages
Russian (ru)
Other versions
RU2245887C2 (en
Inventor
ВЕРТЕР Чарльз А. МАК
Йиквинг ФЕНГ
КЕРН Джон П. МАК
Нина Л. САММЕРС
Николас Р. СТЭЙТЕН
Филип Р. СТРИТЕР
Джон К. МИННЕРЛИ
Нэнси И. МИНСТЕР
Сьюзн Л. ВУЛЬФ
Original Assignee
Джи. Ди. Сирл Энд Ко.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джи. Ди. Сирл Энд Ко. filed Critical Джи. Ди. Сирл Энд Ко.
Publication of RU99111071A publication Critical patent/RU99111071A/en
Application granted granted Critical
Publication of RU2245887C2 publication Critical patent/RU2245887C2/en

Links

Images

Claims (1)

Текст формулы заявки в факсимильном виде (см. чертежи)The text of the application formula in facsimile form (see drawings)
RU99111071/13A 1996-10-25 1997-10-23 Hemopoietic protein (variants), dna sequence, method for preparing hemopoietic protein, method for selective expansion of hemopoietic cells, method for producing dendritic cells, method for stimulating for producing hemopoietic cells in patient, pharmaceutical composition, method for treatment RU2245887C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2962996P 1996-10-25 1996-10-25
US60/029,629 1996-10-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2005105360/13A Division RU2005105360A (en) 1996-10-25 2005-02-24 MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS

Publications (2)

Publication Number Publication Date
RU99111071A true RU99111071A (en) 2001-04-27
RU2245887C2 RU2245887C2 (en) 2005-02-10

Family

ID=21850035

Family Applications (2)

Application Number Title Priority Date Filing Date
RU99111071/13A RU2245887C2 (en) 1996-10-25 1997-10-23 Hemopoietic protein (variants), dna sequence, method for preparing hemopoietic protein, method for selective expansion of hemopoietic cells, method for producing dendritic cells, method for stimulating for producing hemopoietic cells in patient, pharmaceutical composition, method for treatment
RU2005105360/13A RU2005105360A (en) 1996-10-25 2005-02-24 MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2005105360/13A RU2005105360A (en) 1996-10-25 2005-02-24 MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS

Country Status (17)

Country Link
EP (1) EP0935663A2 (en)
JP (1) JP2001504689A (en)
KR (1) KR100497423B1 (en)
AR (1) AR010041A1 (en)
AU (1) AU725547B2 (en)
BR (1) BR9713668A (en)
CA (1) CA2268742A1 (en)
CZ (1) CZ295843B6 (en)
IL (1) IL129565A0 (en)
NO (1) NO991948L (en)
NZ (1) NZ335382A (en)
PL (1) PL333023A1 (en)
RO (1) RO120919B1 (en)
RU (2) RU2245887C2 (en)
TW (2) TW200413407A (en)
WO (1) WO1998017810A2 (en)
ZA (1) ZA979607B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
BR9808514A (en) * 1997-04-11 2000-05-23 Searle & Co Chimeric proteins of the flt3 ligand
BR9905867A (en) * 1998-11-06 2001-01-23 Bio Sidus S A Recombinant human erythropoietin-producing cell line and the recombinant human erythropoietin produced by this cell
WO2002101047A1 (en) * 2001-06-12 2002-12-19 Smithkline Beecham Corporation Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities
NZ530545A (en) 2001-07-11 2006-10-27 Maxygen Holdings Ltd Specific conjugates comprising a polypeptide exhibiting G-CSF activity and a non-polypeptide moiety
DE602004023956D1 (en) 2003-08-18 2009-12-17 Univ California POLYPEPTIDE DISPLAY LIBRARIES AND METHOD FOR THE PRODUCTION AND USE THEREOF
US7381805B2 (en) 2005-06-01 2008-06-03 Maxygen Holdings, Ltd. Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP1919931A4 (en) 2005-08-31 2010-01-20 Univ California CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USE THEREOF
WO2007098548A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
US8293685B2 (en) 2007-07-26 2012-10-23 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
WO2015069489A1 (en) 2013-11-06 2015-05-14 Merck Patent Gmbh Predictive biomarker for hypoxia-activated prodrug therapy
JP2022527322A (en) * 2019-03-28 2022-06-01 オリオニス バイオサイエンシズ，インコーポレイテッド FMS-like tyrosine kinase 3 ligand (FLT3L) -based chimeric protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2069746A1 (en) * 1990-09-28 1992-03-29 Jonathan I. Rosen Hybrid growth factors
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Similar Documents

Publication Publication Date Title
RU2002104574A (en) 2-Arylimino-2,3-dihydro-thiazoles and their use as ligands of somatostatin receptors
TR199600001A2 (en) Estrogen agonists / antagonists.
TR199800375A3 (en) Selant compositions.
ID24583A (en) 1,2,3,4-TETRAHIDRONAFTALENA SUBSTITUTED SITES
RU99111071A (en) MULTIFUNCTIONAL CHIMERIC AGONISTS OF HEMOPOETHIC RECEPTORS
RU2001111046A (en) Pesticidal proteins
TR199501601A2 (en) Cooler.
FI955503A (en) The connecting device
ID23772A (en) COMPOSITIONS THROUGH THE MOUTH
NO991948L (en) Multifunctional chimeric hematopoietic receptor agonists
TR199501645A2 (en) Mouth compositions.
FI953527A0 (en) The extended-nip
TR199501389A2 (en) Adesion receptor antagonists (counterparts).
EP0684670A3 (en) Brush holder.
DE69835972D1 (en) The image scanning
FR2721390B1 (en) Anti-arcuate sleeve.
DE69712037D1 (en) The eductor
EP0705672A3 (en) Compositions with difluor-methoxy-2,2,2-trifluoroethane
RU98108603A (en) MULTIFUNCTIONAL HEMOPOETHIC RECEPTOR AGONISTS
FI971594A0 (en) The connection arrangement
ID20352A (en) HERBISIDA 3,5-DIFLUOROPIRIDIN MATERIALS
ZA978233B (en) The use of protein as anti-retroviral agents.
NL1001779A1 (en) Holder.
RU98113788A (en) COMPOUNDS HAVING PROPERTIES OF RELEASE HORMONE HORMONE
ES1028121Y (en) ARTICULATED MOP.